Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Genmab A S (PK) (GNMSF)
Genmab A S (PK) (GNMSF) Actualités

GNMSF

Genmab A S (PK) (GNMSF)

Genmab A S (PK)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:GNMSF

1 2 3 4 5 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
06/11/2024	17h11	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:GNMSF	Genmab A S (PK)
10/06/2020	13h34	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:GNMSF	Genmab A S (PK)
30/03/2020	23h16	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	USOTC:GNMSF	Genmab A S (PK)
07/02/2020	14h56	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:GNMSF	Genmab A S (PK)
14/08/2019	15h27	Edgar (US Regulatory)	Unknown (sec Staff)	USOTC:GNMSF	Genmab A S (PK)
19/07/2019	12h02	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)	USOTC:GNMSF	Genmab A S (PK)
18/07/2019	15h32	Edgar (US Regulatory)	Securities Registration (ads, Immediate) (f-6ef)	USOTC:GNMSF	Genmab A S (PK)
18/07/2019	12h01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:GNMSF	Genmab A S (PK)
18/07/2019	01h56	Edgar (US Regulatory)	Registration of Additional Securities (up to 20%, Foreign Issuer) (f-1mef)	USOTC:GNMSF	Genmab A S (PK)
17/07/2019	23h25	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	USOTC:GNMSF	Genmab A S (PK)
16/07/2019	14h55	Edgar (US Regulatory)	Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)	USOTC:GNMSF	Genmab A S (PK)
16/07/2019	14h06	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-1/a)	USOTC:GNMSF	Genmab A S (PK)
15/07/2019	23h02	Edgar (US Regulatory)	Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)	USOTC:GNMSF	Genmab A S (PK)
15/07/2019	20h38	Edgar (US Regulatory)	Certification by the Exchange Approving Securities for Listing (cert)	USOTC:GNMSF	Genmab A S (PK)
12/07/2019	22h53	Edgar (US Regulatory)	Securities Registration (section 12(b)) (8-a12b)	USOTC:GNMSF	Genmab A S (PK)
28/05/2019	22h29	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-1)	USOTC:GNMSF	Genmab A S (PK)
31/07/2014	20h50	GlobeNewswire Inc.	GSK and Genmab Announce Positive Interim Result for Phase III Study of Ofatumumab as Maintenance Therapy for Relapsed CLL	USOTC:GNMSF	Genmab A S (PK)
23/07/2014	13h11	GlobeNewswire Inc.	Second Quarter 2014 Net Sales Figures for Arzerra(r)	USOTC:GNMSF	Genmab A S (PK)
18/07/2014	15h18	GlobeNewswire Inc.	Genmab Announces Phase III Study of Daratumumab in Front Line Multiple Myeloma	USOTC:GNMSF	Genmab A S (PK)
14/07/2014	15h59	GlobeNewswire Inc.	Genmab to Receive Milestone Payment in DuoBody Platform Collaboration with Janssen	USOTC:GNMSF	Genmab A S (PK)
07/07/2014	16h23	GlobeNewswire Inc.	Genmab Reaches USD 25 Million Milestone in Daratumumab Collaboration with Janssen	USOTC:GNMSF	Genmab A S (PK)
03/07/2014	15h38	GlobeNewswire Inc.	GSK and Genmab Receive EU Authorization for Arzerra(tm) (ofatumumab) as First-Line Treatment for Chronic Lymphocytic Leukemia...	USOTC:GNMSF	Genmab A S (PK)
27/06/2014	20h27	GlobeNewswire Inc.	GSK and Genmab announce top-line results from a Phase III study of ofatumumab versus physicians' choice for bulky fludarabine...	USOTC:GNMSF	Genmab A S (PK)
04/06/2014	08h27	GlobeNewswire Inc.	Genmab Announces DuoBody and HexaBody Platform Collaboration With Undisclosed Biotechnology Company	USOTC:GNMSF	Genmab A S (PK)
30/05/2014	17h04	GlobeNewswire Inc.	Genmab Announces Ofatumumab Development Plans in RRMS and NMO	USOTC:GNMSF	Genmab A S (PK)
23/05/2014	15h21	GlobeNewswire Inc.	GSK and Genmab Receive CHMP Positive Opinion for Arzerra(tm) in Combination with Chlorambucil or Bendamustine as a First-line...	USOTC:GNMSF	Genmab A S (PK)
19/05/2014	20h21	GlobeNewswire Inc.	GSK and Genmab Announce Topline Results from a Pivotal Head to Head Study of Ofatumumab in Combination With Chemotherapy vs R...	USOTC:GNMSF	Genmab A S (PK)
07/05/2014	17h11	GlobeNewswire Inc.	Genmab Announces Financial Results for the First Quarter of 2014	USOTC:GNMSF	Genmab A S (PK)
01/05/2014	21h09	GlobeNewswire Inc.	Genmab Announces New Phase III Study of Daratumumab in Multiple Myeloma & Improves 2014 Financial Guidance	USOTC:GNMSF	Genmab A S (PK)
30/04/2014	13h11	GlobeNewswire Inc.	First Quarter 2014 Net Sales Figures for Arzerra	USOTC:GNMSF	Genmab A S (PK)

Showing the most relevant articles for your search:USOTC:GNMSF

1 2 3 4 5 Suivant >>

Credit Agricole

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales